Comprehensive Thyroid Tumour Testing with ThyroTrack

If you or a loved one has a thyroid nodule, it is important to determine whether it is benign or malignant. ThyroTrack provides crucial information for accurate diagnosis, surgical planning, and treatment management.
Here are some benefits of the ThyroTrack Test:

• Accurate Diagnosis: The thyroid cancer screening identifies genetic markers to confirm whether the nodule is cancerous or not
• Personalised Treatment: Helps decide the best treatment approach, including surgery or targeted therapies
• Avoiding Unnecessary Surgery: Prevents unwarranted thyroid surgeries, preserves natural thyroid function and reduces the need for lifelong hormone replacement

Accurate differentiation is essential for effective treatment. ThyroTrack looks at specific genetic changes to determine if a nodule is cancerous.
For example:

• BRAF mutation: Indicates the nodule is very likely to be cancerous.
• RAS mutation: Suggests an 84% chance that the nodule is cancerous
• RET and NTRK fusions: Linked to more aggressive types of thyroid cancer.

This information helps doctors recommend appropriate interventions, ensuring the best outcomes for patients.

he liquid biopsy test results provide insights into the existence of circulating tumour cells (CTCs) or cell-free DNA (cfDNA) in the bloodstream.

• A positive result may indicate the presence of cancer, necessitating further investigation or treatment options.
• Conversely, a negative result can suggest the absence of detectable tumour markers, though it does not rule out cancer entirely.

Understanding these results is crucial for determining the appropriate next steps in cancer management. Discuss your results with a doctor for comprehensive interpretation. For more details, visit MedGenome.

he liquid biopsy test results provide insights into the existence of circulating tumour cells (CTCs) or cell-free DNA (cfDNA) in the bloodstream.

• A positive result may indicate the presence of cancer, necessitating further investigation or treatment options.
• Conversely, a negative result can suggest the absence of detectable tumour markers, though it does not rule out cancer entirely.

Understanding these results is crucial for determining the appropriate next steps in cancer management. Discuss your results with a doctor for comprehensive interpretation. For more details, visit MedGenome.